Chronic venous insufficiency: the genetic influence

Marc-Antoine Pistorius1

  • 1Department of Vascular Medicine, Hôtel-Dieu, place Alexis Ricordeau, 44000 Nantes, France.

Angiology
|August 26, 2003
PubMed

Insights

Heredity significantly impacts varicose disease. This study used genetic analysis in families to identify potential mutations predisposing to the condition, revealing a strong genetic component.

Area of Science:

  • Genetics
  • Medical Science
  • Molecular Biology

Background:

  • Varicose disease of the lower limbs is influenced by multiple factors, including heredity, age, sex, and lifestyle.
  • While heredity's role is clinically recognized, its precise impact and genetic basis remain underexplored, with limited molecular genetics studies.
  • Existing twin studies suggest various inheritance patterns, highlighting the need for deeper genetic investigation.

Purpose of the Study:

  • To identify specific gene mutations predisposing individuals to varicose disease.
  • To investigate the genetic underpinnings of varicose disease using a reverse genetics and linkage analysis approach.
  • To explore genetic heterogeneity in varicose disease by studying multiple families.

Main Methods:

  • Conducted linkage studies and reverse genetics in families with segregating varicose disease.
  • Analyzed genetic data from a first family with autosomal dominant varicose disease, identifying potential genetic loci.
  • Performed whole-genotype analysis in a second family to identify novel loci due to genetic heterogeneity.

Main Results:

  • Identified 3 potential genetic loci in the first family, though no candidate genes were pinpointed initially.
  • The second family's analysis did not confirm the initial loci, suggesting genetic heterogeneity.
  • A new potential locus of interest has been identified in the second family.

Conclusions:

  • The genetic factor plays a definitive and significant role in the development of varicose disease.
  • Genetic heterogeneity is likely a key factor in the complex inheritance of varicose disease.
  • Further research, including gene sequencing and analysis of additional families, is crucial to fully elucidate the genetic basis of varicose disease.

Related Concept Videos

Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...